How Semaglutide Works Mechanism of Action Semaglutide is a GLP-1 receptor agonist, which means it mimics the action of the natural hormone glucagon-like peptide-1 (GLP-1)
Understanding these considerations and potential side effects is crucial before starting Semaglutide, emphasizing the importance of discussing individual risks with a healthcare professional for informed decision-making
CEO Brian Lian framed the differentiation as the only dual agonist molecule with the potential to dose monthly or to allow transition from subcutaneous to oral administration for weight maintenance. Risk: Viking is pre-revenue, with a 2025 net loss of $359.64 million and a cash position that fell from $903 million at the start of 2025 to $706 million at year-end
doi: 10.1038/s41586-023-06255-6 47 LiWLiangLLiuSYiHZhouY
2 ARR=absolute risk reduction
But it is also about access, adherence, regulation, and where the metabolic health space is heading next